The nuclear medicine market is expected to exceed more than US$ 5.0 billion by 2024 growing at around 9.0% CAGR for the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Cardinal Health, Inc. (U.S.), GE Healthcare (U.K.), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada), Advanced Accelerator Applications S.A. (France), Bayer Healthcare (Germany), Lantheus Medical Imaging, Inc. (U.S.), IBA Molecular Imaging (Belgium), and Mallinckrodt plc (Ireland).. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
Browser Full Report @: https://www.marketresearchengine.com/reportdetails/nuclear-medicine-market
The scope of the report includes a detailed study of global and regional markets for various types of nuclear medicine market with the reasons given for variations in the growth of the industry in certain regions.
Nuclear medicine market is special category in medical branch used for diagnosis and treatment of disease in a safe and painless way. Nuclear medicine contain radioactive material which combined called as radiopharmaceutical. The small quantity of radiopharmaceutical is given into human body in the form of injection or swallowing. It goes to specific location of a body where there could be disease or abnormality. It emits radiation called gamma rays and contains gamma camera which helps nuclear medicine physician to see inside the body. It takes pictures of inner body which helps physician to diagnose patients’ disease.
This report provides:
1) An overview of the global market for nuclear medicine and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for nuclear medicine.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Reasons to buy this Report:
1) Obtain the most up to date information available on all active and planned nuclear medicine industry globally.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of nuclear medicine industry and unit capacity data.
4) Assess your competitor’s refining portfolio and its evolution.
The Nuclear Medicine Market has been segmented as below:
The Global Nuclear Medicine Market is segmented on the lines of Procedural Volume Segment Analysis, Type Analysis, Application Analysis and Regional Analysis. By Procedural Volume Segment Analysis this market is segmented on the basis of Diagnostics, SPECT Radiopharmaceuticals, PET Radiopharmaceuticals, Therapeutics, Beta Emitters, Alpha Emitters and Brachytherapy Isotopes. By Type Analysis this market is segmented on the basis of Diagnostics, SPECT Radiopharmaceuticals, Tc-99, Tl-201, Ga-67, I-123, PET Radiopharmaceuticals, F-18, Ru-82, Others, Therapeutics, Beta Emitters, I-131, Sm-153, Rh-186, Y-90, Lu-177, Others, Alpha, Emitters, Ra-223, Brachytherapy Isotopes, I-125, Ir-192, Pa-103, Cs-131 and Others.
By Application Analysis this market is segmented on the basis of Diagnostics, SPECT, Cardiology, Lymphoma, Thyroid, Neurology, Others, PET, Oncology, Cardiology, Neurology, Others, Therapeutics, Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Others. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
The important factors driving the nuclear medicine market are advances in radiotracers and alpha radio immunotherapy-based targeted cancer treatment. SPECT and PET scans usage has been increasing to detect diseases like cancer which is driving the nuclear medicine market. Raising the incidence of cancer and cardiac ailments are also responsible for growing the nuclear medicine market. The nuclear medicine market is also having some restraints such as strict regulatory and global Good Manufacturing Practice guidelines. One of the major restraint is that most of the hospital still rely on conventional diagnostic procedures and not able to shift to nuclear medicine due to cost and availability issues. The life of radiopharmaceuticals is small so that sometimes the use of this is restricted.
Request Sample Report from here:https://www.marketresearchengine.com/reportdetails/nuclear-medicine-market
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
126.96.36.199 Investments Through Public-Private Partnerships to Modernize Diagnostic Imaging Centers
188.8.131.52 Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
184.108.40.206 Advances in Radiotracers
220.127.116.11 Increasing Incidence and Prevalence of Cancer and Cardiac Ailments
18.104.22.168 Shorter Half-Life of Radiopharmaceuticals
22.214.171.124 High Cost of Nuclear Medicine Equipment
126.96.36.199 High Demand in Emerging Markets
188.8.131.52 Upcoming Radioisotopes
184.108.40.206 Use of Radiopharmaceuticals in Neurological Applications
220.127.116.11 Shutdown of Nuclear Reactors
6 Nuclear Medicine Market, By Type
7 Nuclear Medicine Market, By Application
8 Nuclear Medicine Market, By Procedural Volume
9 Global Nuclear Medicine Market, By Region
10 Global Nuclear Medicine Market, By Region
11 Competitive Landscape
12 Company Profiles
12.2 Cardinal Health, Inc.
12.3 Mallinckrodt PLC
12.4 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
12.5 Lantheus Medical Imaging, Inc.
12.6 Bayer AG
12.7 Bracco Imaging S.P.A
12.8 Eczacibasi-Monrol Nuclear Products
12.9 Nordion, Inc. (A Subsidiary of Sterigenics International LLC.)
12.10 Advanced Accelerator Applications S.A.
12.11 IBA Molecular
Other Related Market News :
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States